Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Mayne Pharma is pleased to announce that it has entered into a binding agreement to acquire a portfolio of U.S. generic products from Teva and Allergan for cash consideration of $652 million.
read more
Agilent Technologies Inc. announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active ...
read more
Worldwide Clinical Trials has expanded its Site Alliance Collaboration with new partners across the United States and Europe.
read more
Tuesday, October 14, 2025
SteriPack, a contract design and manufacturing organization (CDMO) serving pharmaceutical and medical device industries, has officially changed its trading name to Ensera. The rebranding marks an expansion of services and a strategic shift in ...
read more
Tuesday, September 26, 2017
CRF Health opens their Romania office and adds a new VP of Global Services, Adina Tapalaga.
read more
Altasciences have entered into an agreement with Amador Bioscience, a translational and consulting clinical research organization located in China and the U.S.
read more
Wednesday, January 15, 2025
Dr. Vince Clinical Research (DVCR) announced the expansion of its research campus by constructing a new 5,000-square-foot administration building in Overland Park, Kansas.
read more
Wednesday, November 08, 2017
Bracket announced the addition of Christopher Crucitti, Chief Commercial Officer to its global executive team.
read more
LabConnect has appointed Dr. Anthony Todd Everhart to serve as medical director.
read more
Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab.
read more
VGXI, Inc., a contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines and National Resilience, Inc. (Resilience), a technology-focused biomanufacturing ...
read more
Moffitt Cancer Center announced today the launch of a first-of-its-kind contract research organization (CRO) focused on accelerating immunotherapy research. The subsidiary will provide a one-stop-shop for pharmaceutical and biotech companies to ...
read more
Thursday, October 29, 2015
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has approved Yervoy (ipilimumab) 10 mg/kg for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes ...
read more
Thursday, September 30, 2021
Alcami, a leading United States-based contract development and manufacturing organization (CDMO), announced an additional $31 million investment to expand its sterile development and manufacturing operation in Charleston, SC.
read more
Tuesday, October 31, 2017
PPD announced it was awarded a seven-year contract under the Clinical Research Support Services program of the Division of AIDS, NIAID, part of the NIH.
read more